Consolidated Net Income/Loss (Quarterly)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

GSK PLC Sponsored ADR (GSK) had Consolidated Net Income/Loss of $973.18M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$11.42B
Net Income	$851.67M
Cost of Goods Sold	$3.52B
Gross Profit	$7.91B
Operating Expenses	$9.95B
Operating Income	$1.47B
Non-Operating Income/Expense	$-197.90M
Pre-Tax Income	$1.27B
Normalized Pre-Tax Income	$1.28B
Income after Taxes	$973.18M
Income from Continuous Operations	$973.18M
Consolidated Net Income/Loss	$973.18M
Normalized Income after Taxes	$974.72M
EBIT	$1.47B
EBITDA	$857.04M
Weighted-Average Shares Outstanding (Basic)	2.03B
Weighted-Average Shares Outstanding (Diluted)	2.06B
Earnings per Share (EPS) (Basic)	$0.43
Earnings per Share (EPS) (Diluted)	$0.41
Balance Sheet Financials
Current Assets	$23.09B
Property, Plant, and Equipment	$12.29B
Long-Term Assets	$57.51B
Total Assets	$80.60B
Current Liabilities	$28.21B
Long-Term Debt	$19.40B
Long-Term Liabilities	$31.35B
Total Liabilities	$59.56B
Common Equity	$21.04B
Tangible Shareholders Equity	$-10.30B
Shareholders Equity	$21.04B
Common Shares Outstanding	2.16B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$10.21B
Cash Flow from Investing Activities	$-5.58B
Cash Flow from Financial Activities	$-4.86B
Beginning Cash	$4.49B
End Cash	$4.23B
Increase/Decrease in Cash	$-258.47M
Stock-Based Compensation	$493.19M
Common Stock Dividends Paid	$-3.38B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.82
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.48
Debt to Equity Ratio	1.11
Gross Margin	69.23%
Operating Margin	12.88%
EBIT Margin	12.88%
EBITDA Margin	--
Pre-Tax Profit Margin	11.15%
Profit Margin	7.45%
Free Cash Flow	$8.46B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.45
Receiveable Turnover	1.12
Days Sales in Receivables	80.60
Return on Equity	4.63%
Return on Tangible Equity	-9.45%
Return on Assets	1.21%
Return on Investments	2.41%
Book Value Per Share	$9.75
Free Cash Flow per Share	$4.11
Operating Cash Flow per Share	$4.96

Data from Zacks Investment Research, Inc.